BDBM766751 N-[3-cyclopropyl-4-[[4-(2-methoxyethyl)piperazin-1-yl]methyl]phenyl]-3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-benzamide::US12398142, Compound CD-1-002

SMILES COCCN1CCN(CC2C=CC(NC(=O)c3ccc(C)c(C#Cc4cnc5cccnn45)c3)=CC2C2CC2)CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 766751   

TargetTyrosine-protein kinase ABL1(Human)
Emory University

US Patent
LigandPNGBDBM766751(N-[3-cyclopropyl-4-[[4-(2-methoxyethyl)piperazin-1...)
Affinity DataIC50: 0.643nMAssay Description:Compounds were tested against the Abl1 target kinase and showed potencies between 0.30 and 0.64 nanomolar, compared to nilotinib which showed a poten...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/5/2025
Entry Details
US Patent